Richard N. Bamford

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia”.

Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia

Translational Oncology(2020)10.1016/j.tranon.2020.100913

N/A

0DataRank · unranked

13 citations

Yuquan Lin, Meili Zhang, Bonita R. Bryant, Michael Petrus, Richard N. Bamford +5 more

IL15 and Anti–PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-0496

N/A

0DataRank · unranked

16 citations

Richard N. Bamford, Elijah F. Edmondson, Thomas A. Waldmann, Wei Chen

Accessory cells precondition naïve T cells and regulatory T cells for cytokine-mediated proliferation

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2217562120

N/A

0DataRank · unranked

4 citations

Richard N. Bamford, Bonita R. Bryant, Yutaka Tagaya, Thomas A. Waldmann, Noriko Sato

Data from IL15 and Anti–PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors

(2023)10.1158/1078-0432.c.6531092

N/A

0DataRank · unranked

0 citations

Richard N. Bamford, Elijah F. Edmondson, Thomas A. Waldmann, Wei Chen

Data from IL15 and Anti–PD-1 Augment the Efficacy of Agonistic Intratumoral Anti-CD40 in a Mouse Model with Multiple TRAMP-C2 Tumors

(2023)10.1158/1078-0432.c.6531092.v1

N/A

0DataRank · unranked

0 citations

Richard N. Bamford, Elijah F. Edmondson, Thomas A. Waldmann, Wei Chen